ATE433317T1 - Medizinische aerosolformulierung von antidiabetika - Google Patents

Medizinische aerosolformulierung von antidiabetika

Info

Publication number
ATE433317T1
ATE433317T1 AT01900300T AT01900300T ATE433317T1 AT E433317 T1 ATE433317 T1 AT E433317T1 AT 01900300 T AT01900300 T AT 01900300T AT 01900300 T AT01900300 T AT 01900300T AT E433317 T1 ATE433317 T1 AT E433317T1
Authority
AT
Austria
Prior art keywords
aerosol formulation
antidiabetic drugs
medical aerosol
medical
medicinal aerosol
Prior art date
Application number
AT01900300T
Other languages
English (en)
Inventor
Akwete Adjei
Anthony Cutie
John Sun
Frederick Sexton
Original Assignee
Aeropharm Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeropharm Technology Inc filed Critical Aeropharm Technology Inc
Application granted granted Critical
Publication of ATE433317T1 publication Critical patent/ATE433317T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01900300T 2000-01-25 2001-01-02 Medizinische aerosolformulierung von antidiabetika ATE433317T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17792200P 2000-01-25 2000-01-25
US09/702,939 US6540983B1 (en) 2000-01-25 2000-10-31 Medical aerosol formulation
PCT/US2001/000028 WO2001054741A1 (en) 2000-01-25 2001-01-02 A medicinal aerosol formulation

Publications (1)

Publication Number Publication Date
ATE433317T1 true ATE433317T1 (de) 2009-06-15

Family

ID=26873780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900300T ATE433317T1 (de) 2000-01-25 2001-01-02 Medizinische aerosolformulierung von antidiabetika

Country Status (11)

Country Link
US (1) US6540983B1 (de)
EP (1) EP1289573B1 (de)
JP (1) JP2003520829A (de)
CN (1) CN1235641C (de)
AT (1) ATE433317T1 (de)
AU (2) AU2001224716B2 (de)
CA (1) CA2396785C (de)
DE (1) DE60138948D1 (de)
ES (1) ES2328556T3 (de)
MX (1) MXPA02007188A (de)
WO (1) WO2001054741A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN101238047B (zh) * 2005-08-08 2010-06-16 诺瓦提斯公司 用于定量吸入器的隔热筒罐
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (de) 2006-02-22 2015-07-10 Mannkind Corp
US7819800B2 (en) * 2006-12-15 2010-10-26 Ethicon Endo-Surgery, Inc. Fully automated iris seal for hand assisted laparoscopic surgical procedures
US8197404B2 (en) * 2006-12-15 2012-06-12 Ethicon Endo-Surgery, Inc. Handoscopy interwoven layered seal laparoscopic disk
US7967748B2 (en) * 2006-12-15 2011-06-28 Ethicon Endo-Surgery, Inc. Resiliently supported seal cap for hand assisted laparoscopic surgical procedures
JP2011500850A (ja) * 2007-10-24 2011-01-06 マンカインド コーポレイション Ｇｌｐ−１による副作用を防止する方法
EP2060268A1 (de) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmazeutische Zusammensetzungen für die Zufuhr von Peptiden über die Lunge oder Nase
US8757146B2 (en) 2008-02-07 2014-06-24 University Of Washington Through Its Center For Commercialization Circumferential aerosol device
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
JP6339371B2 (ja) 2011-03-03 2018-06-06 インペル ニューロファーマ インコーポレイテッド 経鼻薬物送達デバイス
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
CN103619485B (zh) 2011-05-09 2017-08-08 英倍尔药业股份有限公司 用于鼻腔药物递送的喷嘴
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
WO2014164730A2 (en) 2013-03-12 2014-10-09 The Board Of Trustees Of The Leland Stanford Junior University Modulation of cellular dna repair activity to intercept malignancy
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
EP2991713B1 (de) 2013-04-28 2019-06-19 Impel Neuropharma Inc. Medizinischer einzeldosisbehälter
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN108498920A (zh) * 2015-05-16 2018-09-07 苏州汉方医药有限公司 由手动悬浮微颗粒发生器和丹参或丹参酮组成的药盒
MX2018002895A (es) 2015-09-10 2018-07-06 Impel Neuropharma Inc Dispositivo de administracion nasal en linea.
EP3713626A4 (de) 2017-11-21 2021-08-18 Impel Neuropharma Inc. Intranasale vorrichtung mit einlassschnittstelle
WO2019104205A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with dip tube
BR112020013750A8 (pt) 2018-01-05 2022-10-18 Impel Neuropharma Inc Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
JP7317020B2 (ja) 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
US11517548B2 (en) 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
WO2020142206A1 (en) 2019-01-03 2020-07-09 Impel Neuropharma, Inc. Nasal drug delivery device
CN114025816A (zh) 2019-05-17 2022-02-08 英倍尔药业股份有限公司 一次性鼻腔给送装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2348264A1 (fr) 1976-04-16 1977-11-10 Montedison Spa Composition de gaz propulseurs pour aerosols
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5011678A (en) 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
FI913899A7 (fi) 1989-02-23 1991-08-19 Rorer Int Holdings Inc Terapeuttiset aerosoliseokset
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
GB9202519D0 (en) 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
EP0681491B1 (de) * 1993-01-29 2000-12-13 Aradigm Corporation Intrapulmonares hormonabgabesystem
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
ATE416755T1 (de) * 1994-03-07 2008-12-15 Nektar Therapeutics Verfahren und zusammensetzung für die pulmonale darreichung von insulin
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
BR9913284A (pt) * 1998-08-28 2001-05-15 Lilly Co Eli Métodos para administrar peptìdeos insulinotrópicos

Also Published As

Publication number Publication date
EP1289573A4 (de) 2003-05-14
EP1289573B1 (de) 2009-06-10
AU2001224716B2 (en) 2005-10-13
AU2471601A (en) 2001-08-07
CA2396785A1 (en) 2001-08-02
CN1235641C (zh) 2006-01-11
DE60138948D1 (de) 2009-07-23
ES2328556T3 (es) 2009-11-16
EP1289573A1 (de) 2003-03-12
CN1427730A (zh) 2003-07-02
MXPA02007188A (es) 2002-12-09
US6540983B1 (en) 2003-04-01
WO2001054741A1 (en) 2001-08-02
JP2003520829A (ja) 2003-07-08
CA2396785C (en) 2011-06-21

Similar Documents

Publication Publication Date Title
ATE433317T1 (de) Medizinische aerosolformulierung von antidiabetika
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
MY124146A (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
MY123193A (en) Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
CY1107939T1 (el) Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη
EP1295609A4 (de) Medikamente mit gemischten aktiven stoffen
DE69932835D1 (de) Medizinische aerosolzubereitung
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
BR0015188A (pt) Composições farmacêuticas
UY27175A1 (es) Nueva sal succinato de o-desmetil- venlafaxina
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
BR0015605A (pt) Composição e uso
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
BR0010914A (pt) Composto medicamento agente profilático ou terapêutico, e, uso do composto
BR0107564A (pt) Composição de gliburida
ATE292453T1 (de) Antivirale arznei
DE69531098D1 (de) Piperidine und pyrrolidine
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
ATE394136T1 (de) Inhalationsgerät für pulverförmige substanzen
WO2001082874A3 (en) A medicinal aerosol formulation
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
ATE360428T1 (de) Analgetisches arzneimittel
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties